For research use only. Not for therapeutic Use.
Core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC<sub>50</sub> = 1.1 <span class=/’symbol/’>μ</span>M). Represses RUNX1/CBF<span class=/’symbol/’>β</span>-dependent transactivation in reporter assays and inhibits transcriptional regulation by RUNX1 and CBF<span class=/’symbol/’>β</span>. Reduces leukemia burden in a mouse model. Attenuates RUNX1-dependent hematopoiesis in zebrafish embryos. Also a Tat antagonist; inhibits HIV-1 replication <em>in vitro</em>.
Catalog Number | I011003 |
CAS Number | 30195-30-3 |
Synonyms | Alternative Name: CBFβ-Runx1 inhibitor II |
Molecular Formula | C13H10ClN3O |
Purity | ≥95% |
Target | Transcription Factors |
Solubility | Soluble to 100 mM in DMSO |
Storage | Store at +4C |
IUPAC Name | 7-chloro-5-(1H-pyrrol-2-yl)-1,3-dihydro-1,4-benzodiazepin-2-one |
InChI | InChI=1S/C13H10ClN3O/c14-8-3-4-10-9(6-8)13(11-2-1-5-15-11)16-7-12(18)17-10/h1-6,15H,7H2,(H,17,18) |
InChIKey | XWNMORIHKRROGW-UHFFFAOYSA-N |
SMILES | C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CN3 |